Back to Journals » Therapeutics and Clinical Risk Management » Volume 2 » Issue 3

Oral paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease

Total article views   HTML views PDF downloads Totals
4,471 Dovepress* 4,471+ 1,606 6,077
Totals 4,471 1,606 6,077
*Since 15 September 2006
+Since July 2016

View citations on Google Scholar